This topic contains a solution. Click here to go to the answer

Author Question: The nurse suspects that a client has an infection. Which assessment findings support that suspicion? ... (Read 110 times)

future617RT

  • Hero Member
  • *****
  • Posts: 543
The nurse suspects that a client has an infection. Which assessment findings support that suspicion?
 
  1. Heart rate of 110 and rapid, shallow respirations
  2. Temperature of 37C and increased heart rate
  3. Respirations of 12/minute and increased heart rate
  4. Respirations of 10/minute and decreased heart rate

Question 2

A client has been advised to take a low-dose aspirin daily for prophylaxis of adverse cardiac events. The client states, I can't take aspirin because it upsets my stomach. Can I take ibuprofen instead? How should the nurse respond?
 
  1. Ibuprofen works differently than aspirin.
  2. Ibuprofen is not safe when used with your anticoagulant therapy.
  3. Ibuprofen has no effect on blood coagulation.
  4. Taking ibuprofen will significantly increase your risk of respiratory failure.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

asdfasdf

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

Correct Answer: 1
Rationale 1: Clients experiencing infection present with an increased heart rate and rapid, shallow respirations.
Rationale 2: This temperature is normal.
Rationale 3: This is a normal respiratory rate.
Rationale 4: Clients experiencing inflammation and infection do not present with a decreased heart rate or respirations.
Global Rationale: The systemic manifestations of inflammation associated with an infection are elevated temperature above 39C (102F), pulse rate greater than 90 beats/minute, respirations greater than 20 breaths/minute, and a white blood cell count greater than 12,000/mm3.

Answer to Question 2

Correct Answer: 1
Rationale 1: Because ibuprofen has less effect on coagulation, it is not used for the prophylaxis of adverse cardiac events.
Rationale 2: Although nonaspirin NSAIDs affect blood coagulation, the action is short-lived, and they are relatively safe to use with anticoagulants.
Rationale 3: Although nonaspirin NSAIDs affect blood coagulation, the action is short-lived.
Rationale 4: In general, nonaspirin NSAIDs do not increase the risk of respiratory failure.
Global Rationale: There are important differences between aspirin and the ibuprofen-like agents in their effects on the blood and heart. Although ibuprofen-like drugs affect blood coagulation, their action is short lived and they are relatively safe to use with anticoagulants. Because they have less antiplatelet effect, the ibuprofen-like agents are not used for the prophylaxis of adverse cardiovascular events. In fact, some of the nonaspirin NSAIDs such as indomethacin and sulindac significantly increase the risk of cardiovascular events. Caution should be used with all the nonaspirin NSAIDs when they are given for prolonged periods to patients with a history of cardiac disease, but do not increase risk of respiratory failure



future617RT

  • Hero Member
  • *****
  • Posts: 543
Both answers were spot on, thank you once again




 

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

Studies show that systolic blood pressure can be significantly lowered by taking statins. In fact, the higher the patient's baseline blood pressure, the greater the effect of statins on his or her blood pressure.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library